AbbVie Inc. (NYSE: ABBV) is a large market cap stock with a market cap of 105544.45. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 20.01, a forward P/E of 11.9 and EPS of 3.34. At a stock price of 66.4 (-0.57%) it has a dividend yield of 3.41%.
EPS growth for the last five years have been 3.50%, more recently this last year it has grown by 185.20%. The next year growth is going to be about 18.10% and more long-term 16.03% after five years. EPS growth quarter over quarter is 32.50%. Sales growth for the past five years have been 7.90% and sales growth quarter over quarter is 17.80%.
For performance, AbbVie Inc. the past week has seen a gain of 3.62%. For the last month performance for AbbVie Inc. is 7.43%. While the last quarter is 9.06% and half year, 26.07%. Finally for the year, performance is -0.53%.
The 52-week high for AbbVie Inc., is at -2.57%, and for the 52-week low it comes to a value of 50.36%. The 20-day simple moving average is 6.72% and 14.54% for the 200-day simple moving average.
Volatility for the week is at 1.55%, and for the month it is 1.54%. AbbVie Inc., has a target price of 70.17.
In terms of debt, long term debt/equity is *TBA, and for total debt/equity AbbVie Inc. has *TBA. The gross margin is 79.80%, while operating margin is 36.40%, the profit margin is *TBA. The current ratio is *TBA and the quick ratio is *TBA.
Insider ownership is at 0.10%, with instituitional ownership at 70.50%. AbbVie Inc. has a payout ratio of *TBA. With the total shares outstanding coming to 1580.48. The shares float is 1580.48, with the float short at 3.83%, with short ratio coming to 6.72.
In terms of returns, the return on assets see AbbVie Inc., get *TBA, with its returns on investment at 16.90%. Return on equity is *TBA. So will the investors see the target price of 70.17, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.